<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513476430</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513476430</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional <italic>CLOCK</italic> gene rs1554483 G/C polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Qian</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513476430">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Chang-Quan</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513476430">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname><given-names>Xiu-Ying</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513476430">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Song-Bing</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513476430">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname><given-names>Xue-Mei</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513476430">1</xref>
<xref ref-type="corresp" rid="corresp1-0300060513476430"/>
</contrib>
</contrib-group>
<aff id="aff1-0300060513476430"><label>1</label>Department of Geriatrics, The West China Hospital of Sichuan University, Sichuan Province, China</aff>
<aff id="aff2-0300060513476430"><label>2</label>Department of Geriatrics, The Third Hospital of Mianyang, Mianyang, Sichuan Province, China</aff>
<author-notes>
<corresp id="corresp1-0300060513476430">Dr Xue-Mei Zhang, Department of Geriatrics, The West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan Province, 610041, China. Email: <email>zxm0709@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>2</issue>
<fpage>340</fpage>
<lpage>346</lpage>
<history>
<date date-type="received"><day>28</day><month>10</month><year>2012</year></date>
<date date-type="accepted"><day>10</day><month>12</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s)2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="sec13-0300060513476430"><title>Objective</title>
<p>To examine the association between the circadian locomotor output cycles kaput (<italic>CLOCK</italic>) gene rs1554483 G/C polymorphism and susceptibility to Alzheimer's disease in Chinese people.</p>
</sec>
<sec id="sec14-0300060513476430"><title>Methods</title>
<p>This case–control study determined apolipoprotein E (<italic>APOE</italic>) and <italic>CLOCK</italic> rs1554483 G/C genotypes using polymerase chain reaction restriction fragment length polymorphism.</p>
</sec>
<sec id="sec15-0300060513476430"><title>Results</title>
<p>Unrelated patients with Alzheimer's disease (<italic>n</italic> = 130) and healthy controls (<italic>n</italic> = 188) were analysed for an association between the <italic>CLOCK</italic> gene rs1554483 G/C polymorphism and susceptibility to Alzheimer's disease. In the whole sample and in <italic>APOE</italic> ɛ4 isoform noncarriers, the prevalence of <italic>CLOCK</italic> gene rs1554483 G allele carriers was significantly higher in patients with Alzheimer's disease than in controls. Among <italic>APOE</italic> ɛ4 carriers, the prevalence of <italic>CLOCK</italic> rs1554483 G allele carriers was not significantly different between patients with Alzheimer's disease and controls.</p>
</sec>
<sec id="sec16-0300060513476430"><title>Conclusion</title>
<p>Among <italic>APOE</italic> ɛ4 noncarriers, but not <italic>APOE</italic> ɛ4 carriers, the <italic>CLOCK</italic> rs1554483 G allele was associated with increased susceptibility to Alzheimer's disease.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Alzheimer's disease</kwd>
<kwd>apolipoprotein E <italic>(APOE)</italic></kwd>
<kwd><italic>APOE</italic> ɛ4 isoform</kwd>
<kwd>circadian locomotor output cycles kaput (<italic>CLOCK</italic>)</kwd>
<kwd><italic>CLOCK</italic> gene rs1554483 G/C</kwd>
<kwd>polymorphism</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513476430" sec-type="intro"><title>Introduction</title>
<p>Alzheimer's disease is an age-associated neurodegenerative disease caused by multiple factors, including genetic factors,<sup><xref ref-type="bibr" rid="bibr1-0300060513476430">1</xref><xref ref-type="bibr" rid="bibr2-0300060513476430"/><xref ref-type="bibr" rid="bibr3-0300060513476430"/>–<xref ref-type="bibr" rid="bibr4-0300060513476430">4</xref></sup> with over 200 genes thought to be involved in its pathogenesis.<sup><xref ref-type="bibr" rid="bibr5-0300060513476430">5</xref></sup> Functional genomic studies reveal that lipid metabolism dyshomeostasis and sleep/wake disorders are associated with Alzheimer's disease-related genes.<sup><xref ref-type="bibr" rid="bibr6-0300060513476430">6</xref>,<xref ref-type="bibr" rid="bibr7-0300060513476430">7</xref></sup> Biological, genetic and epidemiological data support the link between the apolipoprotein E (<italic>APOE</italic>) gene, located on chromosome 19q13.2, and susceptibility to Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr8-0300060513476430">8</xref><xref ref-type="bibr" rid="bibr9-0300060513476430"/>–<xref ref-type="bibr" rid="bibr10-0300060513476430">10</xref></sup> The presence of the allele for the <italic>APOE</italic> ɛ4 isoform, which is the only confirmed genetic risk factor for Alzheimer's disease, increases the risk of developing this condition in a dose-related fashion, and is associated with ∼40–70% of cases.<sup><xref ref-type="bibr" rid="bibr10-0300060513476430">10</xref></sup></p>
<p>The key gene involved in the regulation of circadian rhythm is the circadian locomotor output cycles kaput (<italic>CLOCK</italic>) gene.<sup><xref ref-type="bibr" rid="bibr11-0300060513476430">11</xref>,<xref ref-type="bibr" rid="bibr12-0300060513476430">12</xref></sup> Both the <italic>CLOCK</italic> and <italic>APOE</italic> genes are involved in lipid metabolism pathways, with the <italic>APOE</italic> ɛ4 allele and <italic>CLOCK</italic> rs1554483 G carrier polymorphism both being associated with a high susceptibility to obesity.<sup><xref ref-type="bibr" rid="bibr12-0300060513476430">12</xref><xref ref-type="bibr" rid="bibr13-0300060513476430"/>–<xref ref-type="bibr" rid="bibr14-0300060513476430">14</xref></sup> Sleep disorders and other disturbances of circadian rhythm are also confirmed to be risk factors for Alzheimer's disease. The <italic>CLOCK</italic> rs1554483 G/C polymorphism is related to sleep disorders, suggesting that <italic>CLOCK</italic> may be potential candidate gene for therapy and a marker for increased risk of Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr15-0300060513476430">15</xref>,<xref ref-type="bibr" rid="bibr16-0300060513476430">16</xref></sup></p>
<p>The present case–control study examined the association between the <italic>CLOCK</italic> rs1554483 G/C polymorphism and susceptibility to Alzheimer's disease.</p>
</sec>
<sec id="sec2-0300060513476430" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513476430"><title>Study population</title>
<p>Between January 2010 and September 2011, consecutive patients with Alzheimer's disease were recruited from a primary care setting by specialists in geriatrics, according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association criteria.<sup><xref ref-type="bibr" rid="bibr17-0300060513476430">17</xref></sup> The primary care setting was a section of the Department of Geriatrics of The Third Hospital of Mianyang, Mianyang, Sichuan Province, China. Normal healthy controls, without Alzheimer's disease but similar to the patients in terms of age, sex, daily activities, sleep quality and health status, were volunteers selected from patients attending the Third Hospital of Mianyang for routine examination.</p>
<p>Medical examinations (including liver and renal function tests, abdominal ultrasound examination and cardiac colour Doppler ultrasound) were carried out on all participants. Cognitive function was measured by the Mini Mental state examination (MMSE).<sup><xref ref-type="bibr" rid="bibr18-0300060513476430">18</xref></sup> Daily activities were reported by participants and their family members, and sleep quality was measured using the Pittsburgh Sleep Quality Index.<sup><xref ref-type="bibr" rid="bibr19-0300060513476430">19</xref></sup> In addition, health status was evaluated according to medical records. Patients with a prior diagnosis of cardiovascular, cerebrovascular or peripheral vascular disease, sleep apnoea syndrome, or chronic renal failure were excluded from the study.</p>
<p>Written informed consent was obtained from all participants (as well as their legal proxies). The Research Ethics Committee of Sichuan University approved the study.</p>
</sec>
<sec id="sec4-0300060513476430"><title>Genotyping</title>
<p>Genotyping for the <italic>APOE</italic> and <italic>CLOCK</italic> genes was carried out as described previously.<sup><xref ref-type="bibr" rid="bibr20-0300060513476430">20</xref>,<xref ref-type="bibr" rid="bibr21-0300060513476430">21</xref></sup> Fasting whole blood was drawn from the antecubital vein at 07:00 h am in all subjects to control for diurnal variation. The blood samples were then anticoagulated using 35 µg/ml warfarin and stored at −80°C until analysis. Total RNA was isolated from 2 ml of venous blood using a RNA isolation kit from QIAGEN (Valencia, CA, USA). RNA samples were purified using an RNeasy™ Kit (QIAGEN) and treated with DNase I (30 Kunitz units) to remove any trace of genomic DNA, according to the manufacturer's instructions. cDNA was reverse transcribed (RT) from RNA using the FastQuant RT Kit (TIANGEN Biotech [Beijing], Beijing, China). PCR amplification of the cDNA was performed in a 25 -μl reaction volume containing 1 × QIAGEN polymerase chain reaction (PCR) buffer, 1 × QIAGEN Q-solution, 0.6 µm primers, 0.2 mm of each deoxynucleotide triphosphate (Invitrogen, Carlsbad, CA, USA), and 0.6 U HotStar Taq DNA polymerase (QIAGEN). PCR primers for the <italic>APOE</italic> and <italic>CLOCK</italic> genes were designed, based on the human gene, using primer sequences that have been reported previously.<sup><xref ref-type="bibr" rid="bibr20-0300060513476430">20</xref>,<xref ref-type="bibr" rid="bibr21-0300060513476430">21</xref></sup> The PCR conditions were as follows: initial incubation at 95°C for 15 min, followed by 36 cycles of denaturation at 94°C for 30 s, annealing at 56°C for 1 min and elongation at 72°C for 40 s. PCR products were sequenced and characterized to confirm their identity, and the genotypes of <italic>APOE</italic> and <italic>CLOCK</italic> gene rs1554483 G/C were determined.<sup><xref ref-type="bibr" rid="bibr20-0300060513476430">20</xref>,<xref ref-type="bibr" rid="bibr21-0300060513476430">21</xref></sup></p>
</sec>
<sec id="sec5-0300060513476430"><title>Statistical analyses</title>
<p>All statistical analyses were carried out using the SPSS® software package, version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows®. Allele frequencies and genotype distribution for the <italic>APOE</italic> and <italic>CLOCK</italic> genes in patients with Alzheimer's disease and control subjects were determined by an allele-counting method and analysed using Pearson's χ<sup>2</sup>-test. Between-group baseline characteristics were compared using the χ<sup>2</sup>-test for categorical variables and unpaired Student's <italic>t</italic>-test for continuous variables. A power analysis was carried out using the Genetic Power Calculator (<ext-link ext-link-type="uri" xlink:href="http://pngu.mgh.harvard.edu/purcell/gpc/cc2.html">http://pngu.mgh.harvard.edu/purcell/gpc/cc2.html</ext-link>) to determine the sample size, in accordance with a previous study.<sup><xref ref-type="bibr" rid="bibr22-0300060513476430">22</xref></sup> A <italic>P</italic>-value &lt; 0.05 was considered to be statistically significant; all <italic>P</italic>-values were two sided.</p>
</sec>
</sec>
<sec id="sec6-0300060513476430" sec-type="results"><title>Results</title>
<p>The study enrolled 318 participants: 130 patients with Alzheimer's disease and 188 controls. Participants' demographic and clinical characteristics are given in <xref ref-type="table" rid="table1-0300060513476430">Table 1</xref>. Compared with healthy controls, patients with Alzheimer's disease had significantly lower MMSE scores (<italic>t</italic> = 4.23, <italic>P</italic> &lt; 0.0001), and a significantly higher prevalence of <italic>APOE</italic> ɛ4 (χ<sup>2 </sup>= 20.799, <italic>P</italic> &lt; 0.0001). There was no significant between-group difference in sleep quality.
<table-wrap id="table1-0300060513476430" position="float"><label>Table 1.</label><caption><p>Demographic and clinical characteristics of patients with Alzheimer's disease and age-matched healthy controls.</p></caption>
<graphic alternate-form-of="table1-0300060513476430" xlink:href="10.1177_0300060513476430-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th>Alzheimer's disease <italic>n</italic> = 130</th>
<th>Controls <italic>n</italic> = 188</th>
<th>χ<sup>2</sup>- or <italic>t</italic>-value</th>
<th>Statistical significance<sup><xref ref-type="table-fn" rid="table-fn2-0300060513476430">a</xref></sup></th>
</tr></thead>
<tbody align="left">
<tr>
<td>Age, years, range</td>
<td>76.25 ± 4.15, 65–85</td>
<td>75.89 ± 3.76, 65–85</td>
<td>0.381</td>
<td>NS</td>
</tr>
<tr>
<td>Sex</td>
</tr>
<tr>
<td> Male</td>
<td>70 (53.85)</td>
<td>101 (53.72)</td>
<td>0.005</td>
<td>NS</td>
</tr>
<tr>
<td> Female</td>
<td>60 (46.15)</td>
<td>87 (46.28)</td>
</tr>
<tr>
<td>MMSE score</td>
<td>19.72 ± 4.80</td>
<td>28.23 ± 1.73</td>
<td>4.23</td>
<td><italic>P</italic> &lt; 0.0001</td>
</tr>
<tr>
<td><italic>APOE</italic> ɛ4</td>
<td>37 (28.46)</td>
<td>34 (18.09)</td>
<td>20.799</td>
<td><italic>P</italic> &lt; 0.0001</td>
</tr>
<tr>
<td>PSQI</td>
<td>6.67 ± 2.59</td>
<td>6.97 ± 2.66</td>
<td>0.864</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513476430"><p>Data presented as mean ± SD or <italic>n</italic> (%) of patients.</p></fn>
<fn id="table-fn2-0300060513476430"><label>a</label><p>χ<sup>2</sup>-test for categorical variables; unpaired Student's <italic>t</italic>-test for continuous variables.</p></fn>
<fn id="table-fn3-0300060513476430"><p>APOE ɛ4, apolipoprotein E ɛ4 isoform; MMSE, Mini Mental State Examination;<sup><xref ref-type="bibr" rid="bibr18-0300060513476430">18</xref></sup> PSQI, Pittsburgh Sleep Quality Index;<sup><xref ref-type="bibr" rid="bibr19-0300060513476430">19</xref></sup> NS, no statistically significant differences (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap></p>
<p>In the whole study population, there were no statistically significant between-group differences in the prevalence of <italic>CLOCK</italic> gene rs1554483 G/C genotypes. Patients with Alzheimer's disease had a significantly higher prevalence of G allele carriers (χ<sup>2 </sup>= 6.148, <italic>P</italic> = 0.009) compared with controls (<xref ref-type="table" rid="table2-0300060513476430">Table 2</xref>).
<table-wrap id="table2-0300060513476430" position="float"><label>Table 2.</label><caption><p>Comparison of allele and genotype frequencies of <italic>CLOCK</italic> rs1554483 C/G polymorphism and <italic>APOE</italic> ɛ4 isoform in patients with Alzheimer's disease and age-matched healthy controls.</p></caption>
<graphic alternate-form-of="table2-0300060513476430" xlink:href="10.1177_0300060513476430-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Group/Characteristic</th>
<th>Alzheimer's disease <italic>n</italic> = 130</th>
<th>Controls <italic>n</italic> = 188</th>
<th>χ<sup>2</sup>-value</th>
<th>Statistical significance<sup><xref ref-type="table-fn" rid="table-fn5-0300060513476430">a</xref></sup></th>
</tr></thead>
<tbody align="left">
<tr>
<td>All participants</td>
</tr>
<tr>
<td> Allele</td>
</tr>
<tr>
<td>  C</td>
<td>183 (70.38)</td>
<td>297 (78.99)</td>
</tr>
<tr>
<td>  G</td>
<td>77 (29.62)</td>
<td>79 (21.01)</td>
<td>6.148</td>
<td><italic>P</italic> = 0.009</td>
</tr>
<tr>
<td> Genotype</td>
</tr>
<tr>
<td>  C/C</td>
<td>74 (56.92)</td>
<td>128 (68.09)</td>
</tr>
<tr>
<td>  C/G</td>
<td>35 (26.92)</td>
<td>41 (21.81)</td>
</tr>
<tr>
<td>  G/G</td>
<td>21 (16.15)</td>
<td>19 (10.11)</td>
<td>4.583</td>
<td>NS</td>
</tr>
<tr>
<td><italic>APOE</italic> ɛ4 carriers</td>
<td><italic>n</italic> = 37</td>
<td><italic>n</italic> = 34</td>
</tr>
<tr>
<td> Allele</td>
</tr>
<tr>
<td>  C</td>
<td>48 (64.86)</td>
<td>42 (61.76)</td>
</tr>
<tr>
<td>  G</td>
<td>26 (35.14)</td>
<td>26 (38.24)</td>
<td>0.147</td>
<td>NS</td>
</tr>
<tr>
<td> Genotype</td>
</tr>
<tr>
<td>  C/C</td>
<td>22 (59.46)</td>
<td>13 (38.24)</td>
</tr>
<tr>
<td>  C/G</td>
<td>11 (29.73)</td>
<td>12 (35.29)</td>
</tr>
<tr>
<td>  G/G</td>
<td>4 (10.81)</td>
<td>9 (26.47)</td>
<td>4.162</td>
<td>NS</td>
</tr>
<tr>
<td><italic>APOE</italic> ɛ4 noncarriers</td>
<td><italic>n</italic> = 93</td>
<td><italic>n</italic> = 154</td>
</tr>
<tr>
<td> Allele</td>
</tr>
<tr>
<td>  C</td>
<td>128 (68.82)</td>
<td>259 (84.09)</td>
</tr>
<tr>
<td>  G</td>
<td>58 (31.18)</td>
<td>49 (15.91)</td>
<td>15.944</td>
<td><italic>P</italic> &lt; 0.0001</td>
</tr>
<tr>
<td> Genotype</td>
</tr>
<tr>
<td>  C/C</td>
<td>52 (55.91)</td>
<td>115 (74.68)</td>
</tr>
<tr>
<td>  C/G</td>
<td>24 (25.81)</td>
<td>29 (18.83)</td>
</tr>
<tr>
<td>  G/G</td>
<td>17 (18.28)</td>
<td>10 (6.49)</td>
<td>11.702</td>
<td><italic>P</italic> = 0.003</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0300060513476430"><p>Data presented as <italic>n</italic> (%) incidence.</p></fn>
<fn id="table-fn5-0300060513476430"><label>a</label><p>Allele frequencies and genotype distribution of patients with Alzheimer's disease and control subjects were determined by an allele-counting method and analysed with Pearson's χ<sup>2</sup>-test.</p></fn>
<fn id="table-fn6-0300060513476430"><p>APOE ɛ4, apolipoprotein E ɛ4 isoform; CLOCK, circadian locomotor output cycles kaput; NS, no statistically significant differences (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Among <italic>APOE</italic> ɛ4 noncarriers, there was a significant between-group difference in the prevalence of the <italic>CLOCK</italic> rs1554483 G/C genotype (χ<sup>2 </sup>= 11.702, <italic>P</italic> = 0.003). In addition, patients with Alzheimer's disease had a higher prevalence of G carriers (χ<sup>2 </sup>= 12.347, <italic>P</italic> &lt; 0.0001) compared with controls. Among <italic>APOE</italic> ɛ4 carriers, there were no significant between-group differences in <italic>CLOCK</italic> rs1554483 G/C genotype or allele prevalence (<xref ref-type="table" rid="table2-0300060513476430">Table 2</xref>).</p>
</sec>
<sec id="sec7-0300060513476430" sec-type="discussion"><title>Discussion</title>
<p>The present study demonstrated a significantly higher proportion of <italic>APOE</italic> ɛ4 carriers in the Alzheimer's disease patient group than in the control group (28.46% versus 18.09%, χ<sup>2 </sup>= 20.799; <xref ref-type="table" rid="table1-0300060513476430">Table 1</xref>). There was a difference between <italic>APOE</italic> ɛ4 noncarriers and carriers in terms of the <italic>CLOCK</italic> rs1554483 G/C polymorphism and an association with Alzheimer's disease. In the whole study population, there were three times more <italic>APOE</italic> ɛ4 noncarriers than <italic>APOE</italic> ɛ4 carriers. In <italic>APOE</italic> ɛ4 noncarriers and in the whole study population, the <italic>CLOCK</italic> rs1554483 G allele appeared to be associated with an increased risk of Alzheimer's disease, with a stronger association observed in <italic>APOE</italic> ɛ4 noncarriers. No significant association between the <italic>CLOCK</italic> rs1554483 G allele and Alzheimer's disease was seen in <italic>APOE</italic> ɛ4 carriers, however. The association of <italic>CLOCK</italic> rs1554483 G allele with an increased risk of Alzheimer's disease was only observed in <italic>APOE</italic> ɛ4 noncarriers. Thus, it would appear that the link between the <italic>CLOCK</italic> rs1554483 G allele and an increased risk of Alzheimer's disease is only relevant in <italic>APOE</italic> ɛ4 noncarriers.</p>
<p>To the best of the authors' knowledge, the present study is the first to evaluate an association between the <italic>CLOCK</italic> rs1554483 G/C polymorphism and Alzheimer's disease, and to show a link between the two. To date, the presence of the <italic>APOE</italic> ɛ4 allele has been the only confirmed genetic risk factor for Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr8-0300060513476430">8</xref><xref ref-type="bibr" rid="bibr9-0300060513476430"/>–<xref ref-type="bibr" rid="bibr10-0300060513476430">10</xref></sup> The <italic>APOE</italic> gene is involved in the regulation of metabolism, and the <italic>APOE</italic> ɛ4 allele has been related to an increased risk of metabolic syndrome, which is also a known risk factor for Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr23-0300060513476430">23</xref></sup> The <italic>CLOCK</italic> gene rs1554483 G allele is also linked with increased metabolic syndrome. In terms of increased risk of Alzheimer's disease, therefore, the <italic>CLOCK</italic> rs1554483 G allele and <italic>APOE</italic> ɛ4 allele may share the same mechanism, which may involve metabolic disruption.<sup><xref ref-type="bibr" rid="bibr12-0300060513476430">12</xref>,<xref ref-type="bibr" rid="bibr24-0300060513476430">24</xref>,<xref ref-type="bibr" rid="bibr25-0300060513476430">25</xref></sup> Further investigation is required, to confirm such an association.</p>
<p>There was a difference between <italic>APOE</italic> ɛ4 carriers and noncarriers in terms of the association between the <italic>CLOCK</italic> rs1554483 G/C polymorphism and Alzheimer's disease, in the present study. Among the <italic>APOE</italic> ɛ4 carriers, no association between the <italic>CLOCK</italic> gene rs1554483 G allele and an increased risk of Alzheimer's disease was observed. Both <italic>APOE</italic> ɛ4 noncarriers and <italic>CLOCK</italic> rs1554483 G carriers showed an increased risk of Alzheimer's disease. When the two factors were present simultaneously, the risk of Alzheimer's disease did not significantly increase over the risk observed for each individual factor. Possible explanations for this include: (i) that, as the prevalence of Alzheimer's disease was already high in the <italic>APOE</italic> ɛ4 carrier or <italic>CLOCK</italic> rs1554483 G allele carrier groups, when they existed simultaneously the increased prevalence was small and did not achieve statistical significance; (ii) the increased risk of Alzheimer's disease in the <italic>CLOCK</italic> rs1554483 G allele and <italic>APOE</italic> ɛ4 carriers occurs via the same mechanism, so that the presence of one factor would be sufficient to start the disease process, and when the other also existed, the increased risk for Alzheimer's disease was negligible.</p>
<p>Finally, <italic>CLOCK</italic> is a key gene regulating circadian rhythm and <italic>CLOCK</italic> rs1554483 G/C polymorphisms are related to the risk of Alzheimer's disease, suggesting that circadian rhythm may also related to Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr12-0300060513476430">12</xref>,<xref ref-type="bibr" rid="bibr24-0300060513476430">24</xref></sup> Circadian rhythm disorders (including sleep/wake cycles, blood-pressure rhythm and thyrotropin-stimulating hormone rhythm) have been confirmed to be risk factors for Alzheimer's disease.<sup><xref ref-type="bibr" rid="bibr15-0300060513476430">15</xref>,<xref ref-type="bibr" rid="bibr16-0300060513476430">16</xref></sup> The present study suggested that circadian rhythm was related to the risk of Alzheimer's disease at a genetic level, and point to a genetic locus that could be related to the development of the disease.</p>
<p>In conclusion, the present study indicated that the <italic>CLOCK</italic> gene rs1554483 G/C polymorphism may be associated with Alzheimer's disease, that <italic>CLOCK</italic> rs1554483 G allele carriers may have a higher risk of developing Alzheimer's disease than noncarriers, and that this association may differ between <italic>APOE</italic> ɛ4 noncarriers and carriers.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgements</title>
<p>The authors thank the staff of the Key Laboratory of Chronobiology of Health Ministry in the Basic and Forensic School of Sichuan University, and the Department of Geriatrics of the Third Hospital of Mianyang, and all study participants (as well as their legal proxies) for their contributions.</p></ack>
<sec id="sec8-0300060513476430"><title>Funding</title>
<p>This work was supported by the Science and Technology Graveness Project of Sichuan Province (2010FZ0061) and the Illustrious Youth Specialist Project of Sichuan Province (2012JQ0050).</p>
</sec>
<sec id="sec9-0300060513476430"><title>Declaration of conflicting interest</title>
<p>The Authors declare that there are no conflicts of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0300060513476430"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>AB</given-names></name><name><surname>Kawas</surname><given-names>CH</given-names></name><name><surname>Peltz</surname><given-names>CB</given-names></name><etal/></person-group>. <article-title>Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia</article-title>. <source>Neurology</source> <year>2012</year>; <volume>79</volume>: <fpage>915</fpage>–<lpage>921</lpage>.</citation></ref>
<ref id="bibr2-0300060513476430"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dartigues</surname><given-names>JF</given-names></name><name><surname>Féart</surname><given-names>C</given-names></name></person-group>. <article-title>Risk factors for Alzheimer disease: aging beyond age?</article-title> <source>Neurology</source> <year>2011</year>; <volume>77</volume>: <fpage>206</fpage>–<lpage>207</lpage>.</citation></ref>
<ref id="bibr3-0300060513476430"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Fitzpatrick</surname><given-names>AL</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Genome-wide analysis of genetic loci associated with Alzheimer disease</article-title>. <source>JAMA</source> <year>2010</year>; <volume>303</volume>: <fpage>1832</fpage>–<lpage>1840</lpage>.</citation></ref>
<ref id="bibr4-0300060513476430"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Miyashita</surname><given-names>A</given-names></name><name><surname>Tsukie</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>for the Japanese Genetic Study Consortium for Alzheimer Disease: Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese</article-title>. <source>Genomics</source> <year>2009</year>; <volume>93</volume>: <fpage>441</fpage>–<lpage>448</lpage>.</citation></ref>
<ref id="bibr5-0300060513476430"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>F</given-names></name><name><surname>Carrasquillo</surname><given-names>MM</given-names></name><name><surname>Pankratz</surname><given-names>VS</given-names></name><etal/></person-group>. <article-title>Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease</article-title>. <source>Neurology</source> <year>2010</year>; <volume>74</volume>: <fpage>480</fpage>–<lpage>486</lpage>.</citation></ref>
<ref id="bibr6-0300060513476430"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yesavage</surname><given-names>JA</given-names></name><name><surname>Noda</surname><given-names>A</given-names></name><name><surname>Hernandez</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>for the Alzheimer's Disease Neuroimaging Initiative: Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease</article-title>. <source>Am J Geriatr Psychiatry</source> <year>2011</year>; <volume>19</volume>: <fpage>635</fpage>–<lpage>643</lpage>.</citation></ref>
<ref id="bibr7-0300060513476430"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Späti</surname><given-names>J</given-names></name><name><surname>Münch</surname><given-names>M</given-names></name><name><surname>Blatter</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Impact of age, sleep pressure and circadian phase on time-of-day estimates</article-title>. <source>Behav Brain Res</source> <year>2009</year>; <volume>201</volume>: <fpage>48</fpage>–<lpage>52</lpage>.</citation></ref>
<ref id="bibr8-0300060513476430"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name></person-group>. <article-title>Apolipoprotein E and Alzheimer disease</article-title>. <source>Neurology</source> <year>2006</year>; <volume>66</volume>(<supplement>suppl 1</supplement>): <fpage>S79</fpage>–<lpage>S85</lpage>.</citation></ref>
<ref id="bibr9-0300060513476430"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bales</surname><given-names>KR</given-names></name><name><surname>Dodart</surname><given-names>JC</given-names></name><name><surname>DeMattos</surname><given-names>RB</given-names></name><etal/></person-group>. <article-title>Apolipoprotein E, amyloid, and Alzheimer disease</article-title>. <source>Mol Interv</source> <year>2002</year>; <volume>2</volume>: <fpage>363</fpage>–<lpage>375, 339</lpage>.</citation></ref>
<ref id="bibr10-0300060513476430"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Sugihara</surname><given-names>S</given-names></name><name><surname>Ogawa</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects</article-title>. <source>J Neuropathol Exp Neurol</source> <year>2001</year>; <volume>60</volume>: <fpage>731</fpage>–<lpage>739</lpage>.</citation></ref>
<ref id="bibr11-0300060513476430"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Rambaud</surname><given-names>J</given-names></name><name><surname>Teboul</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Expression levels of estrogen receptor β are modulated by components of the molecular clock</article-title>. <source>Mol Cell Biol</source> <year>2008</year>; <volume>28</volume>: <fpage>784</fpage>–<lpage>793</lpage>.</citation></ref>
<ref id="bibr12-0300060513476430"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Froy</surname><given-names>O</given-names></name></person-group>. <article-title>Metabolism and circadian rhythms – implications for obesity</article-title>. <source>Endocr Rev</source> <year>2010</year>; <volume>31</volume>: <fpage>1</fpage>–<lpage>24</lpage>.</citation></ref>
<ref id="bibr13-0300060513476430"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garaulet</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><etal/></person-group>. <article-title><italic>CLOCK</italic> genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids</article-title>. <source>Am J Clin Nutr</source> <year>2009</year>; <volume>90</volume>: <fpage>1466</fpage>–<lpage>1475</lpage>.</citation></ref>
<ref id="bibr14-0300060513476430"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>FZ</given-names></name><name><surname>Campain</surname><given-names>AE</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><etal/></person-group>. <article-title>Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension</article-title>. <source>Hypertension</source> <year>2010</year>; <volume>56</volume>: <fpage>319</fpage>–<lpage>324</lpage>.</citation></ref>
<ref id="bibr15-0300060513476430"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Bugge</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism</article-title>. <source>Science</source> <year>2011</year>; <volume>331</volume>: <fpage>1315</fpage>–<lpage>1319</lpage>.</citation></ref>
<ref id="bibr16-0300060513476430"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>DG</given-names></name><name><surname>Stopa</surname><given-names>EG</given-names></name><name><surname>McKee</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration</article-title>. <source>Arch Gen Psychiatry</source> <year>2001</year>; <volume>58</volume>: <fpage>353</fpage>–<lpage>360</lpage>.</citation></ref>
<ref id="bibr17-0300060513476430"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarazin</surname><given-names>M</given-names></name><name><surname>de Souza</surname><given-names>LC</given-names></name><name><surname>Lehéricy</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinical and research diagnostic criteria for Alzheimer's disease</article-title>. <source>Neuroimaging Clin N Am</source> <year>2012</year>; <volume>22</volume>: <fpage>23</fpage>–<lpage>32</lpage>.</citation></ref>
<ref id="bibr18-0300060513476430"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neri</surname><given-names>AL</given-names></name><name><surname>Ongaratto</surname><given-names>LL</given-names></name><name><surname>Yassuda</surname><given-names>MS</given-names></name></person-group>. <article-title>Mini Mental State Examination sentence writing among community-dwelling elderly adults in Brazil: text fluency and grammar complexity</article-title>. <source>Int Psychogeriatr</source> <year>2012</year>; <volume>24</volume>: <fpage>1732</fpage>–<lpage>1737</lpage>.</citation></ref>
<ref id="bibr19-0300060513476430"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casement</surname><given-names>MD</given-names></name><name><surname>Harrington</surname><given-names>KM</given-names></name><name><surname>Miller</surname><given-names>MW</given-names></name><etal/></person-group>. <article-title>Associations between Pittsburgh Sleep Quality Index factors and health outcomes in women with posttraumatic stress disorder</article-title>. <source>Sleep Med</source> <year>2012</year>; <volume>13</volume>: <fpage>752</fpage>–<lpage>758</lpage>.</citation></ref>
<ref id="bibr20-0300060513476430"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gouin</surname><given-names>JP</given-names></name><name><surname>Connors</surname><given-names>J</given-names></name><name><surname>Kiecolt-Glaser</surname><given-names>JK</given-names></name><etal/></person-group>. <article-title>Altered expression of circadian rhythm genes among individuals with a history of depression</article-title>. <source>J Affect Disord</source> <year>2010</year>; <volume>126</volume>: <fpage>161</fpage>–<lpage>166</lpage>.</citation></ref>
<ref id="bibr21-0300060513476430"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elcoroaristizabal Martín</surname><given-names>X</given-names></name><name><surname>Fernández Martínez</surname><given-names>M</given-names></name><name><surname>Galdos Alcelay</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene</article-title>. <source>Dement Geriatr Cogn Disord</source> <year>2011</year>; <volume>32</volume>: <fpage>332</fpage>–<lpage>341</lpage>.</citation></ref>
<ref id="bibr22-0300060513476430"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>Ascertainment through family history of disease often decreases the power of family-based association studies</article-title>. <source>Behav Genet</source> <year>2007</year>; <volume>37</volume>: <fpage>631</fpage>–<lpage>636</lpage>.</citation></ref>
<ref id="bibr23-0300060513476430"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>IJ</given-names></name><name><surname>Hone</surname><given-names>E</given-names></name><name><surname>Foster</surname><given-names>JK</given-names></name><etal/></person-group>. <article-title>Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease</article-title>. <source>Mol Psychiatry</source> <year>2006</year>; <volume>11</volume>: <fpage>721</fpage>–<lpage>736</lpage>.</citation></ref>
<ref id="bibr24-0300060513476430"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa-Kobayashi</surname><given-names>E</given-names></name><name><surname>Ushijima</surname><given-names>K</given-names></name><name><surname>Ando</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Reduced histone H3K9 acetylation of clock genes and abnormal glucose metabolism in ob/ob mice</article-title>. <source>Chronobiol Int</source> <year>2012</year>; <volume>29</volume>: <fpage>982</fpage>–<lpage>993</lpage>.</citation></ref>
<ref id="bibr25-0300060513476430"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>JL</given-names></name><name><surname>Husse</surname><given-names>J</given-names></name><name><surname>Bode</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork</article-title>. <source>PLoS One</source> <year>2012</year>; <volume>7</volume>: <fpage>e37150</fpage>–<lpage>e37150</lpage>.</citation></ref>
</ref-list>
</back>
</article>